Employees of the OLLA-MED LLC center took an active part in the scientific conference, listened to reports from leading scientists, experts from regulatory authorities of the EAEU countries, representatives of research centers, contract research organizations and educational institutions, Russian and foreign pharmaceutical companies. Thanks to the organizers for the opportunity to meet with colleagues face-to-face!
On February 1, 2024, a meeting was held for researchers based on the results of the TT-06 study. At the meeting, the ALK team shared key performance and safety results. In addition, the international coordinator is a researcher, Professor. Monica Gappa and researcher Dr. Remy Gagnon presented scientific presentations and clinical perspectives of the TT-06 study.
The opening of the center was held: patients with erosive GERD will participate in an international, multicenter, prospective, randomized, double–blind, actively controlled, parallel-group study to evaluate the efficacy and safety of tegoprazane, sponsored by Dr. Reddy's Laboratories Ltd, India.
A selection visit was successfully completed to participate in a clinical trial of a biological therapy drug for the treatment of patients with moderate to severe chronic plaque psoriasis, sponsored by Binnopharm Group LLC.
